Carmichael Hill & Associates’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $2.67M | Buy |
3,013
+6
| +0.2% | +$5.32K | 0.95% | 25 |
|
|
2024
Q2 | $2.72M | Sell |
3,007
-5
| -0.2% | -$4.53K | 1.07% | 23 |
|
|
2024
Q1 | $2.34M | Buy |
3,012
+35
| +1% | +$27.2K | 0.93% | 28 |
|
|
2023
Q4 | $1.74M | Sell |
2,977
-50
| -2% | -$29.1K | 0.72% | 30 |
|
|
2023
Q3 | $1.63M | Hold |
3,027
| – | – | 0.75% | 29 |
|
|
2023
Q2 | $1.42M | Sell |
3,027
-3
| -0.1% | -$1.41K | 0.63% | 34 |
|
|
2023
Q1 | $1.04M | Hold |
3,030
| – | – | 0.5% | 46 |
|
|
2022
Q4 | $1.11M | Hold |
3,030
| – | – | 0.57% | 40 |
|
|
2022
Q3 | $980K | Buy |
3,030
+1
| +0% | +$323 | 0.53% | 38 |
|
|
2022
Q2 | $982K | Hold |
3,029
| – | – | 0.52% | 40 |
|
|
2022
Q1 | $867K | Buy |
3,029
+50
| +2% | +$14.3K | 0.4% | 56 |
|
|
2021
Q4 | $823K | Hold |
2,979
| – | – | 0.37% | 52 |
|
|
2021
Q3 | $688K | Hold |
2,979
| – | – | 0.34% | 56 |
|
|
2021
Q2 | $684K | Sell |
2,979
-33
| -1% | -$7.58K | 0.35% | 58 |
|
|
2021
Q1 | $563K | Buy |
3,012
+45
| +2% | +$8.41K | 0.31% | 66 |
|
|
2020
Q4 | $501K | Hold |
2,967
| – | – | 0.3% | 72 |
|
|
2020
Q3 | $439K | Hold |
2,967
| – | – | 0.29% | 67 |
|
|
2020
Q2 | $487K | Hold |
2,967
| – | – | 0.36% | 57 |
|
|
2020
Q1 | $412K | Hold |
2,967
| – | – | 0.36% | 60 |
|
|
2019
Q4 | $390K | Hold |
2,967
| – | – | 0.28% | 73 |
|
|
2019
Q3 | $332K | Buy |
2,967
+36
| +1% | +$4.03K | 0.33% | 79 |
|
|
2019
Q2 | $325K | Hold |
2,931
| – | – | 0.32% | 79 |
|
|
2019
Q1 | $380K | Sell |
2,931
-45
| -2% | -$5.83K | 0.39% | 71 |
|
|
2018
Q4 | $344K | Hold |
2,976
| – | – | 0.39% | 73 |
|
|
2018
Q3 | $319K | Hold |
2,976
| – | – | 0.31% | 78 |
|
|
2018
Q2 | $254K | Hold |
2,976
| – | – | 0.27% | 91 |
|
|
2018
Q1 | $230K | Hold |
2,976
| – | – | 0.25% | 101 |
|
|
2017
Q4 | $251K | Buy |
+2,976
| New | +$251K | 0.27% | 95 |
|